Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03 / VECTITAX study
FI: 4,286
Type: Article
Collaboration
Year: 2016
Writers
Morillo, ED; Messiah, R; Klain, JCA; Fernandez, S.V.; Martinez-Galan, J; Borgonon, MP; Gonzalez-Rivas, C; Daroqui, JC; Berrocal, A; Martinez-Trufero, J; Vera, R; Cruz-Hernandez, JJ
Magazine
Title: ORAL ONCOLOGY
Quartile
- D1